KCNK3 and obstructive sleep apnea syndrome: Therefore, the inhibition of TASK-1 by certain blockers might result in responding or non-responding patients, depending on the targeted tissue and disease, similar to what was observed in the KOALA clinical OSA study utilizing the TASK-1 blocker BAY25861166 or to what is frequently observed in human medicine in general.